Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.35 |
| ▸ | GABRD | O14764 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28258643 | 0.90 | PTGS1 (0.45) | PTGS1PTGS2ALDH1A1HSD17B10ENPEP | |
| SCHEMBL5873778 | 0.88 | PTGS1 (0.47) | PTGS1PTGS2ALDH1A1HSD17B10ENPEP | |
| SCHEMBL28406949 | 0.87 | PTGS1 (0.50) | PTGS1PTGS2ALDH1A1HSD17B10 | |
| SCHEMBL17301050 | 0.81 | PTGS1 (0.46) | PTGS1PTGS2CYP1A2ALDH1A1HPGD | |
| SCHEMBL3046367 | 0.80 | CTSD (0.40) | CYP1A2ALDH1A1HPGDKDM4EPOLB | |
| SCHEMBL17924909 | 0.79 | MGLL (0.37) | PTGS1PTGS2CYP1A2ALDH1A1HPGD | |
| SCHEMBL1535472 | 0.79 | MGLL (0.39) | PTGS1PTGS2CYP1A2ALDH1A1HPGD | |
| SCHEMBL1535518 | 0.78 | MGLL (0.46) | PTGS1PTGS2CYP1A2ALDH1A1HPGD | |
| SCHEMBL27690608 | 0.78 | ENPEP (0.44) | PTGS1PTGS2CYP1A2ALDH1A1HPGD | |
| SCHEMBL29103206 | 0.78 | CYP1A2 (0.33) | PTGS1PTGS2CYP1A2POLBCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540172-B2 | Therapeutic nanoconjugates comprising Stefin A and uses thereof | UNIVERSITAT AUTONOMA DE BARCELONA (UAB) (ES) | 2026-02-03 | — | — | US | disclosed |
| EP-4619417-A1 | NANOCONJUGATES CONTAINING PDGFR-BETA LIGANDS AND USES THEREOF | Universitat Autònoma de Barcelona (ES) | 2025-09-24 | — | — | EP | disclosed |
| US-12408914-B2 | Systems and methods for customizing mechanical strength in stimuli-responsive bioabsorbable materials | CILAG GMBH INTERNATIONAL (CH) | 2025-09-09 | — | — | US | disclosed |
| US-20250243250-A1 | THERAPEUTIC NANOCONJUGATES AND USES THEREOF | UNIV AUTÒNOMA DE BARCELONA UAB (ES) | 2025-07-31 | — | — | US | disclosed |
| EP-4543502-A1 | SYSTEMS AND METHODS FOR CUSTOMIZING MECHANICAL STRENGTH IN STIMULI-RESPONSIVE BIOABSORBABLE MATERIALS | Cilag GmbH International (CH) | 2025-04-30 | — | — | EP | disclosed |
| US-12202866-B2 | Therapeutic nanoconjugates and uses thereof | UNIVERSITAT AUTONOMA DE BARCELONA (UAB) (ES) | 2025-01-21 | — | — | US | disclosed |
| US-20240423617-A1 | SYSTEMS AND METHODS FOR CUSTOMIZING MECHANICAL STRENGTH IN STIMULI-RESPONSIVE BIOABSORBABLE MATERIALS | CILAG GMBH INTERNATIONAL (CH) | 2024-12-26 | — | — | US | disclosed |
| WO-2024261659-A1 | SYSTEMS AND METHODS FOR CUSTOMIZING MECHANICAL STRENGTH IN STIMULI-RESPONSIVE BIOABSORBABLE MATERIALS | CILAG GMBH INTERNATIONAL (CH) | 2024-12-26 | — | — | WO | disclosed |
| US-20240423620-A1 | COMPRESSIBLE SURGICAL ADJUNCTS, CARTRIDGES, AND CARTRIDGE ASSEMBLIES AND METHODS OF MAKING SURGICAL ADJUNCTS | CILAG GMBH INTERNATIONAL (CH) | 2024-12-26 | — | — | US | disclosed |
| US-20240382613-A1 | METHODS AND SYSTEMS FOR ULTRASOUND STIMULATED STRUCTURES AND DELIVERY OF THERAPEUTIC SPECIES | THE PENN STATE RESEARCH FOUNDATION | 2024-11-21 | — | — | US | disclosed |
| EP-3911367-A1 | THERAPEUTIC NANOCONJUGATES AND USES THEREOF | Universitat Autónoma De Barcelona (UAB) (ES) | 2021-11-24 | — | — | EP | disclosed |
| CN-113597318-A | Therapeutic nanoconjugates and uses thereof | 巴塞罗那自治大学(UAB) | 2021-11-02 | — | — | CN | disclosed |
| WO-2021130390-A1 | SCAFFOLD PROTEINS AND THERAPEUTIC NANOCONJUGATES BASED ON NIDOGEN | UNIVERSITAT AUTÒNOMA DE BARCELONA (ES) | 2021-07-01 | — | — | WO | disclosed |
| WO-2020148398-A1 | THERAPEUTIC NANOCONJUGATES AND USES THEREOF | UNIVERSITAT AUTONOMA DE BARCELONA (UAB) (ES) | 2020-07-23 | — | — | WO | disclosed |
| EP-3651809-A1 | THERAPEUTIC NANOCONJUGATES AND USES THEREOF | Universitat Autónoma De Barcelona (UAB) (ES) | 2020-05-20 | — | — | EP | disclosed |
| CN-111093718-A | Therapeutic nanoconjugates and uses thereof | 巴塞罗那自治大学(UAB) | 2020-05-01 | — | — | CN | disclosed |
| WO-2019012157-A1 | THERAPEUTIC NANOCONJUGATES AND USES THEREOF | UNIVERSITAT AUTÒNOMA DE BARCELONA (UAB) (ES) | 2019-01-17 | — | — | WO | disclosed |
| US-8029979-B2 | Method for determining the substrate specificity of an enzyme | JPT PEPTIDE TECHNOLOGIES GMBH (DE) | 2011-10-04 | — | — | US | disclosed |
| US-20060234308-A1 | Method for determining the substrate specificity of an enzymatic activity and a device therefor | JERINI AG (DE) | 2006-10-19 | — | — | US | disclosed |
| US-20040171097-A1 | Method for determining the substrate specificity of an enzymatic activity and a device therefor | JERINI AG (DE) | 2004-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240382613-A1 | METHODS AND SYSTEMS FOR ULTRASOUND STIMULATED STRUCTURES AND DELIVERY OF THERAPEUTIC SPECIES | PAICS, APEX1, ADM2 | PTGS1 954/4885PTGS2 837/4885CYP1A2 2582/4885 |
| US-12540172-B2 | Therapeutic nanoconjugates comprising Stefin A and uses thereof | MYOF, MSTN, NGLY1 | PTGS1 4811/4885PTGS2 4831/4885CYP1A2 4781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.